Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte precursor cell | 7 studies | 24% ± 10% | |
| neuron | 3 studies | 50% ± 23% |
Insufficient scRNA-seq data for expression of DLL3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 504.32 | 2633 / 2642 | 97% | 284.91 | 682 / 705 |
| skin | 17% | 14.60 | 314 / 1809 | 82% | 49.19 | 387 / 472 |
| ovary | 16% | 10.88 | 29 / 180 | 37% | 3.30 | 158 / 430 |
| eye | 0% | 0 | 0 / 0 | 51% | 11.37 | 41 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 31% | 1.49 | 9 / 29 |
| uterus | 1% | 0.25 | 1 / 170 | 30% | 3.24 | 139 / 459 |
| lung | 0% | 0.08 | 1 / 578 | 18% | 4.07 | 203 / 1155 |
| bladder | 0% | 0 | 0 / 21 | 11% | 1.63 | 57 / 504 |
| peripheral blood | 10% | 7.53 | 90 / 929 | 0% | 0 | 0 / 0 |
| adrenal gland | 0% | 0 | 0 / 258 | 9% | 1.11 | 21 / 230 |
| tonsil | 0% | 0 | 0 / 0 | 9% | 1.17 | 4 / 45 |
| thymus | 4% | 2.52 | 27 / 653 | 4% | 0.26 | 27 / 605 |
| stomach | 0% | 0 | 0 / 359 | 8% | 2.13 | 23 / 286 |
| breast | 1% | 0.46 | 4 / 459 | 7% | 0.61 | 80 / 1118 |
| esophagus | 0% | 0.05 | 1 / 1445 | 8% | 0.49 | 14 / 183 |
| intestine | 1% | 0.52 | 8 / 966 | 6% | 0.43 | 31 / 527 |
| prostate | 0% | 0 | 0 / 245 | 3% | 0.17 | 17 / 502 |
| pancreas | 0% | 0 | 0 / 328 | 3% | 0.44 | 6 / 178 |
| kidney | 0% | 0 | 0 / 89 | 3% | 0.19 | 29 / 901 |
| spleen | 2% | 0.86 | 4 / 241 | 0% | 0 | 0 / 0 |
| liver | 0% | 0 | 0 / 226 | 1% | 0.13 | 5 / 406 |
| adipose | 0% | 0.15 | 3 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 0% | 0.04 | 1 / 1335 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
| muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0001501 | Biological process | skeletal system development |
| GO_0007386 | Biological process | compartment pattern specification |
| GO_0050768 | Biological process | negative regulation of neurogenesis |
| GO_0045746 | Biological process | negative regulation of Notch signaling pathway |
| GO_0030154 | Biological process | cell differentiation |
| GO_0007219 | Biological process | Notch signaling pathway |
| GO_0001756 | Biological process | somitogenesis |
| GO_0048339 | Biological process | paraxial mesoderm development |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0016020 | Cellular component | membrane |
| GO_0005112 | Molecular function | Notch binding |
| GO_0005509 | Molecular function | calcium ion binding |
| Gene name | DLL3 |
| Protein name | Delta-like protein 3 (Drosophila Delta homolog 3) (Delta3) Delta like canonical Notch ligand 3 |
| Synonyms | |
| Description | FUNCTION: Inhibits primary neurogenesis. May be required to divert neurons along a specific differentiation pathway. Plays a role in the formation of somite boundaries during segmentation of the paraxial mesoderm (By similarity). . |
| Accessions | M0R177 ENST00000205143.4 [Q9NYJ7-1] ENST00000356433.10 [Q9NYJ7-2] ENST00000596614.5 Q9NYJ7 |